<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T01:51:55Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/33516" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/33516</identifier><datestamp>2026-08-27T07:10:53Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Werstuck, Geoff</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">De Leon, Mark Leonard</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department">Biochemistry and Biomedical Sciences</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2026-08-26T19:53:28Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2026</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://hdl.handle.net/11375/33516</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/2300</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract">Individuals with diabetes mellitus suffers from chronic hyperglycemia and have an increased risk of developing cardiovascular disease. Diabetes is also associated with accelerated atherosclerosis. Research into diabetes have found that associated vascular complications arise from impaired angiogenesis and we theorise reduced vascular support within the arterial wall may contribute to the progression of diabetic atherosclerosis, potentially through altered expression of Vascular Endothelial Growth Factor (VEGF). This study introduced a transgenic mouse model CSF1R-iCretg/0 VEGF164tg/0 apoE-/- to observe if transient macrophage-specific overexpression of VEGF can attenuate atherosclerotic development under hyperglycemic conditions in diabetic murine models.

Experimental CSF1R-iCretg/0 VEGF164tg/0 apoE-/- mice and genetic controls were produced through selective breeding and were randomly enrolled into several treatment groups. Hyperglycemia was induced through multiple low-dose streptozotocin injections or citrate buffer for normoglycemic control at five and seven weeks of age, while transient VEGF overexpression was achieved through tamoxifen-induced Cre recombinase activation or corn oil for vehicle control at either six, 10 or fourteen weeks of age. Plasma angiogenic markers, lipid profiles, tissue morphology, and atherosclerotic progression were assessed.

Hyperglycemic mice demonstrated sustained elevations in blood glucose, reduced body weight, altered circulating angiogenic profiles characterized by increased Ang-2 and decreased endostatin levels, and accelerated atherosclerotic plaques. Transient macrophage-specific VEGF overexpression attenuated atherosclerotic plaque development under chronic hyperglycemia, with female mice exhibiting significant reductions in plaque burden. Both male and female mice demonstrated reduced vascular hypoxia and partial restoration of vasa vasorum density following VEGF induction, without significant changes in macrophage recruitment, and a shift to a focus on increased adaptive Endoplasmic stress response over pro-apoptotic. 

Overall, these findings suggest that transient macrophage-specific VEGF overexpression modifies the vascular microenvironment and may reduce diabetes-associated atherosclerotic progression through reductions in hypoxia, and ER stress response changes.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree">Master of Science (MSc)</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en_US</dim:field>
   <dim:field mdschema="dc" element="subject">Diabetes mellitus</dim:field>
   <dim:field mdschema="dc" element="subject">hyperglycemia</dim:field>
   <dim:field mdschema="dc" element="subject">atherosclerosis</dim:field>
   <dim:field mdschema="dc" element="subject">angiogenesis</dim:field>
   <dim:field mdschema="dc" element="subject">vascular endothelial growth factor (VEGF)</dim:field>
   <dim:field mdschema="dc" element="subject">vasa vasorum</dim:field>
   <dim:field mdschema="dc" element="subject">hypoxia</dim:field>
   <dim:field mdschema="dc" element="title">Investigating the Effects of Transient Overexpression of Vascular Endothelial Growth Factor on Hyperglycemia Induced Accelerated Atherosclerotic Plaque Development and Diabetic Associated Changes in Circulating Angiogenic Factors in Murine Models</dim:field>
   <dim:field mdschema="dc" element="title" qualifier="alternative">VEGF-Mediated Effects on Diabetic Atherosclerosis</dim:field>
   <dim:field mdschema="dc" element="type" lang="en">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">embargo</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>